These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 37673810

  • 1. Platelets as a prognostic factor for patients with adenocarcinoma of the gastroesophageal junction.
    Feka J, Jomrich G, Winkler D, Ilhan-Mutlu A, Kristo I, Paireder M, Rieder E, Bologheanu M, Asari R, Schoppmann SF.
    Langenbecks Arch Surg; 2023 Sep 06; 408(1):351. PubMed ID: 37673810
    [Abstract] [Full Text] [Related]

  • 2. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.
    Zhang F, Chen Z, Wang P, Hu X, Gao Y, He J.
    Tumour Biol; 2016 Jul 06; 37(7):9323-31. PubMed ID: 26779631
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
    Gao L, Zhang H, Zhang B, Zhang L, Wang C.
    Oncotarget; 2017 Feb 28; 8(9):15632-15641. PubMed ID: 28152504
    [Abstract] [Full Text] [Related]

  • 4. High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma.
    Jomrich G, Hollenstein M, John M, Ristl R, Paireder M, Kristo I, Asari R, Schoppmann SF.
    Ann Surg Oncol; 2019 Apr 28; 26(4):976-985. PubMed ID: 30706229
    [Abstract] [Full Text] [Related]

  • 5. Analysis of Perioperative Platelet Indices and Their Prognostic Value in Head and Neck Cancer Patients Treated with Surgery and Postoperative Radiotherapy: A Retrospective Cohort Study.
    Jank BJ, Haas M, Dunkler D, Campion NJ, Brkic FF, Heiduschka G, Kadletz L.
    J Clin Med; 2019 Nov 02; 8(11):. PubMed ID: 31684119
    [Abstract] [Full Text] [Related]

  • 6. Count of platelet and mean platelet volume score: serologic prognostic factor in patients with oral squamous cell carcinoma.
    Park JW, Kim CH, Ha YC, Kim MY, Park SM.
    J Korean Assoc Oral Maxillofac Surg; 2017 Oct 02; 43(5):305-311. PubMed ID: 29142864
    [Abstract] [Full Text] [Related]

  • 7. High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma.
    Jomrich G, Paireder M, Kristo I, Baierl A, Ilhan-Mutlu A, Preusser M, Asari R, Schoppmann SF.
    Ann Surg; 2021 Mar 01; 273(3):532-541. PubMed ID: 31425286
    [Abstract] [Full Text] [Related]

  • 8. The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction.
    Jomrich G, Hollenstein M, John M, Baierl A, Paireder M, Kristo I, Ilhan-Mutlu A, Asari R, Preusser M, Schoppmann SF.
    Oncotarget; 2018 Jan 23; 9(6):6968-6976. PubMed ID: 29467943
    [Abstract] [Full Text] [Related]

  • 9. Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study.
    Chang J, Lin G, Ye M, Tong D, Zhao J, Zhu D, Yu Q, Zhang W, Li W.
    BMC Cancer; 2019 Jan 07; 19(1):15. PubMed ID: 30612568
    [Abstract] [Full Text] [Related]

  • 10. Prognostic Significance of Platelet (PLT) and Platelet to Mean Platelet Volume (PLT/MPV) Ratio During Apatinib Second-Line or Late-Line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients.
    Su R, Zhu J, Wu S, Luo H, He Y.
    Technol Cancer Res Treat; 2022 Jan 07; 21():15330338211072974. PubMed ID: 35072577
    [Abstract] [Full Text] [Related]

  • 11. Prognostic evaluation of resectable colorectal cancer using platelet-associated indicators.
    Qian W, Ge XX, Wu J, Gong FR, Wu MY, Xu MD, Lian L, Wang WJ, Li W, Tao M.
    Oncol Lett; 2019 Jul 07; 18(1):571-580. PubMed ID: 31289529
    [Abstract] [Full Text] [Related]

  • 12. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes.
    Yin JB, Li N, Cui MM, Wang X, Wang RT.
    BMC Gastroenterol; 2020 May 11; 20(1):143. PubMed ID: 32393273
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
    Urabe M, Yamashita H, Watanabe T, Seto Y.
    World J Surg; 2018 Jan 11; 42(1):185-194. PubMed ID: 28741195
    [Abstract] [Full Text] [Related]

  • 14. A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.
    Blank S, Rachakonda S, Keller G, Weichert W, Lordick F, Langer R, Springfeld C, Bruckner T, Becker K, Kumar R, Ott K.
    BMC Cancer; 2014 Feb 03; 14():58. PubMed ID: 24490800
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.
    Wang SC, Chou JF, Strong VE, Brennan MF, Capanu M, Coit DG.
    Ann Surg; 2016 Feb 25; 263(2):292-7. PubMed ID: 25915915
    [Abstract] [Full Text] [Related]

  • 17. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
    Omar M, Tanriverdi O, Cokmert S, Oktay E, Yersal O, Pilancı KN, Menekse S, Kocar M, Sen CA, Ordu C, Goksel G, Meydan N, Barutca S, Turkish Descriptive Oncological Researches Group.
    Clin Respir J; 2018 Mar 25; 12(3):922-929. PubMed ID: 28026133
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy.
    Gensthaler L, Jomrich G, Brugger J, Kollmann D, Paireder M, Bologheanu M, Horn A, Riegler FM, Asari R, Schoppmann SF.
    Langenbecks Arch Surg; 2023 Jun 06; 408(1):227. PubMed ID: 37280384
    [Abstract] [Full Text] [Related]

  • 20. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y, Wang Q, Wang J, Qiao XY, Zhang J, Lin YC, Li Y, Fan LQ, Yang PG, Zhao Q.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb 25; 24(2):128-137. PubMed ID: 33508918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.